The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease

Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosmans, Laura A., Bosch, Lena, Kusters, Pascal J.H., Lutgens, Esther, Seijkens, Tom T.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892683/
https://www.ncbi.nlm.nih.gov/pubmed/32222950
http://dx.doi.org/10.1007/s12265-020-09994-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892683/
https://www.ncbi.nlm.nih.gov/pubmed/32222950
http://dx.doi.org/10.1007/s12265-020-09994-3

Ejemplares similares